<description>Welcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here’s what you need to know for today, March 15, 2024.

Check out the show notes for links to the stories we discussed today at MassDevice.com/podcast.

Conformal Medical this week reported "encouraging" results for its left atrial appendage occlusion device. Fast Five hosts Danielle Kirsh and Sean Whooley discuss what the device does and what doctors think about the device.

Autonomix has completed its first procedures in its pancreatic cancer ablation trial. Learn what the trial will assess, what the technology does and how optimistic executives are.

Axonics won CE mark approval for its fourth-generation rechargeable sacral neuromodulation system. Whooley talks about what the device does and some of the other news Axonics has had recently.

SafeGuard Surgical won an FDA breakthrough nod for its biodegradable stent. Hear more about the stent, which has backing from an NFL quarterback.

Edwards reported "excellent" outcomes with its latest Sapien TAVR study. The Fast Five hosts talk about some of the data points that stuck out.</description>

Welcome to the MassDevice Fast Five medtech news …

Welcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here’s what you need to know for today, March 15, 2024.

Check out the show notes for links to the stories we discussed today at MassDevice.com/podcast.

Conformal Medical this week reported "encouraging" results for its left atrial appendage occlusion device. Fast Five hosts Danielle Kirsh and Sean Whooley discuss what the device does and what doctors think about the device.

Autonomix has completed its first procedures in its pancreatic cancer ablation trial. Learn what the trial will assess, what the technology does and how optimistic executives are.

Axonics won CE mark approval for its fourth-generation rechargeable sacral neuromodulation system. Whooley talks about what the device does and some of the other news Axonics has had recently.

SafeGuard Surgical won an FDA breakthrough nod for its biodegradable stent. Hear more about the stent, which has backing from an NFL quarterback.

Edwards reported "excellent" outcomes with its latest Sapien TAVR study. The Fast Five hosts talk about some of the data points that stuck out.

Edwards reports new outcomes with TAVR; SafeGuard wins breakthrough nod for biodegradable stent

<description>Welcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here’s what you need to know for today, March 14, 2024.

Check out the show notes for links to the stories we discussed today at MassDevice.com/podcast.

Sooma raised $5.5 million for its depression-treating neuromodulation technology. Fast Five hosts Sean Whooley and Danielle Kirsh talk about what the company's technology does and what it plans are for the funds. 

SetPoint Medical won FDA breakthrough designation for its nerve stimulation technology for multiple sclerosis. Hear more about the technology and the executives' optimism about the future of the technology. 

Abbott is launching its latest Navitor TAVI system in the U.S. Whooley talks about the technology and Abbott's TAVR market history. 

GE Healthcare has established a foundation to advance access to healthcare. The Fast Five hosts talk about what the new foundation will focus on and what the future holds. 

A former Stimwave CEO was recently convicted of healthcare fraud. Learn more about what the CEO was found guilty of and how the case unfolded.</description>

Welcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here’s what you need to know for today, March 14, 2024.

Check out the show notes for links to the stories we discussed today at MassDevice.com/podcast.

Sooma raised $5.5 million for its depression-treating neuromodulation technology. Fast Five hosts Sean Whooley and Danielle Kirsh talk about what the company's technology does and what it plans are for the funds. 

SetPoint Medical won FDA breakthrough designation for its nerve stimulation technology for multiple sclerosis. Hear more about the technology and the executives' optimism about the future of the technology. 

Abbott is launching its latest Navitor TAVI system in the U.S. Whooley talks about the technology and Abbott's TAVR market history. 

GE Healthcare has established a foundation to advance access to healthcare. The Fast Five hosts talk about what the new foundation will focus on and what the future holds. 

A former Stimwave CEO was recently convicted of healthcare fraud. Learn more about what the CEO was found guilty of and how the case unfolded.

Former Stimwave CEO convicted of healthcare fraud; GE HealthCare establishes charitable foundation

<description>Welcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here’s what you need to know for today, March 13, 2024.

Check out the show notes for links to the stories we discussed today at MassDevice.com/podcast.

GE HealthCare and Mass General are bringing artificial intelligence to imaging. Fast Five hosts Sean Whooley and Danielle Kirsh discuss the partnership and how it can transform healthcare.

Ascensia and Senseonics have announced new CGM cost savings. Hear more about some of the cost saving initiatives and the devices that are included in the initiatives.

SS Innovations has used its surgical robot in mitral valve replacement procedures. Whooley talks about what the robot does and what people think about its performance. 

3M CEO Mike Roman is stepping down as CEO and a successor has been named. Learn who is taking over the corner office and the optimism they bring to the role.

A recent recall of Abbott's HeartMate communications system is Class I, according to the FDA. The Fast Five hosts talk about the reason behind the recall and if there have been any adverse reports.</description>

Welcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here’s what you need to know for today, March 13, 2024.

Check out the show notes for links to the stories we discussed today at MassDevice.com/podcast.

GE HealthCare and Mass General are bringing artificial intelligence to imaging. Fast Five hosts Sean Whooley and Danielle Kirsh discuss the partnership and how it can transform healthcare.

Ascensia and Senseonics have announced new CGM cost savings. Hear more about some of the cost saving initiatives and the devices that are included in the initiatives.

SS Innovations has used its surgical robot in mitral valve replacement procedures. Whooley talks about what the robot does and what people think about its performance. 

3M CEO Mike Roman is stepping down as CEO and a successor has been named. Learn who is taking over the corner office and the optimism they bring to the role.

A recent recall of Abbott's HeartMate communications system is Class I, according to the FDA. The Fast Five hosts talk about the reason behind the recall and if there have been any adverse reports.

Recall of Abbott HeartMate comms system is Class I; Roman to move out of CEO post at 3M

<description>Welcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here’s what you need to know for today, March 12, 2024.

Check out the show notes for links to the stories we discussed today at MassDevice.com/podcast.

Boston Scientific reported positive results for the agent drug-coated balloon study. Fast Five hosts Danielle Kirsh and Sean Whooley talk about the technology and the data points that stick out.

Medtronic is highlighting the global performance of its MiniMed 780G automated insulin delivery system. Hear about what the new data highlights and some of the most compelling data the company highlighted.

The FDA has cleared Pulse Biosciences' pulsed field ablation electrode technology. Whooley talks about what the PFA electrode technology does and some of the optimism that executives have.

Onward was accepted into an FDA advisory program. The Fast Five hosts talk about the technology that got them into the advisory program and what the acceptance means.

iRhythm closed an offering worth more than $660 million. Learn more about what is included in this offering and what the company plans to use the proceeds for.</description>

Welcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here’s what you need to know for today, March 12, 2024.

Check out the show notes for links to the stories we discussed today at MassDevice.com/podcast.

Boston Scientific reported positive results for the agent drug-coated balloon study. Fast Five hosts Danielle Kirsh and Sean Whooley talk about the technology and the data points that stick out.

Medtronic is highlighting the global performance of its MiniMed 780G automated insulin delivery system. Hear about what the new data highlights and some of the most compelling data the company highlighted.

The FDA has cleared Pulse Biosciences' pulsed field ablation electrode technology. Whooley talks about what the PFA electrode technology does and some of the optimism that executives have.

Onward was accepted into an FDA advisory program. The Fast Five hosts talk about the technology that got them into the advisory program and what the acceptance means.

iRhythm closed an offering worth more than $660 million. Learn more about what is included in this offering and what the company plans to use the proceeds for.

iRhythm closes offering worth more than $660M; FDA accepts Onward BCI into advisory program

<description>Welcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here’s what you need to know for today, March 8, 2024.

Check out the show notes at MassDevice.com/podcast.

Siemens Healthineers launched a new surgical planning tool. Fast Five hosts Chris Newmarker and Sean Whooley examine the latest application of surgical planning and education using the Apple Vision Plus system.

Nanoflex Robotics announced the first U.S. installations of its surgical robot. The hosts take a look at what this robot does and how Nanoflex hopes to use it to improve the treatment of stroke patients.

Biobot Surgical raised $18 million to support its surgical robot. Newmarker and Whooley break down the unique purpose of this company's surgical robot and discuss the potential uses of proceeds.

Roche Diabetes Care unveiled its new CGM technology with predictive AI algorithms. The Fast Five hosts examine the properties of yet another potential competitor in the CGM market and see if the predictive AI capabilities could set it apart from the rest.

The FTC is reportedly looking into Boston Scientific’s acquisition of Axonics. Following a $3.7 billion acquisition, some questions have arisen around antitrust activity. Newmarker and Whooley look at Bloomberg's report on a potential investigation and break down the potential fallout if this acquisition doesn't go through.</description>

Welcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here’s what you need to know for today, March 8, 2024.

Check out the show notes at MassDevice.com/podcast.

Siemens Healthineers launched a new surgical planning tool. Fast Five hosts Chris Newmarker and Sean Whooley examine the latest application of surgical planning and education using the Apple Vision Plus system.

Nanoflex Robotics announced the first U.S. installations of its surgical robot. The hosts take a look at what this robot does and how Nanoflex hopes to use it to improve the treatment of stroke patients.

Biobot Surgical raised $18 million to support its surgical robot. Newmarker and Whooley break down the unique purpose of this company's surgical robot and discuss the potential uses of proceeds.

Roche Diabetes Care unveiled its new CGM technology with predictive AI algorithms. The Fast Five hosts examine the properties of yet another potential competitor in the CGM market and see if the predictive AI capabilities could set it apart from the rest.

The FTC is reportedly looking into Boston Scientific’s acquisition of Axonics. Following a $3.7 billion acquisition, some questions have arisen around antitrust activity. Newmarker and Whooley look at Bloomberg's report on a potential investigation and break down the potential fallout if this acquisition doesn't go through.

Fast Five: FTC may look at Boston Scientific's Axonics buy, Roche unveils new AI-enabled CGM

Welcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up to date on the latest breakthroughs in medical technology with the top five news stories to get your day started. Subscribe and join us every weekday for your daily medtech news roundup.

Fast Five Medtech News Podcast

Details

Recent Episodes